HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Reestablish the Paediatric Regulatory network to accelerate national registration and facilitate in-country registration of specific products under the Collaborative procedure established by WHO.
World Health Organisation (WHO)
Sub-Actions & Milestones
Identify key actions to actively engage high-burden priority countries which are not included in current EMP SRA CRP list- June 2018
-
-
-
Reestablish the Paediatric Regulatory network to accelerate national registration
WHO
-
-
Paedatric HIV high burden countries make use of the WHO collaborative procedure to accelerate in country registration of optimal products. Committement by countries at IAC2018 for specific paedatric products.
-
-
-
Network reestablished by July.
-
-
WHO to include next steps and milestones for the Paediatric Regulatory network and the collaborative procedure.
Facilitate in-country registration of specific products under the Collaborative procedure established by WHO
WHO
-
-
-
-
-
-
Map different pathways for upcoming priority products to guide regulators and innovators when applying through CRP (Collaborative Registration Procedure) - May 2018
-
-
-
Updates
Notes
Responsible